Roche Corleen M.
- SEC CIK
- 0001857905
No open-market purchases or sales filed in the past year.
Current role at each company
- IOVA Iovance Biotherapeutics, Inc.Chief Financial Officeras of Aug 10, 2026
- CGON CG Oncology, Inc.CFOas of Apr 16, 2025
- IMNM Immunome Inc.Chief Financial Officeras of Jun 12, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Roche Corleen M. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CGON CG Oncology, Inc.
CFO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 (view filing) | Jan 29 | 2 days | Roche Corleen M.CFO & Secretary | PPurchase | +2.00K | $19.00 | +$38.0K | New position2.00K after |